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Obesity-related cardiovascular disease (CVD) involves increased sympathetic activity
in men and male animals. Although women exhibit increased visceral fat, metabolic
disorders, inflammation and CVD with obesity, whether body weight gain affects
autonomic control of cardiovascular function in females remain unknown. Due to the lack
of adequate model to mimic the human pathology, this study aimed to develop a murine
model, which would allow studying the sex-specificity of the response of the autonomic
nervous system to obesity and identifying the origin of potential sex-differences. We
tested the hypothesis that sexual dimorphisms in the autonomic response to obesity
disappear in mice matched for changes in body weight, metabolic and inflammatory
disorders. Male and female C57Bl/6 mice were submitted to control (CD) or high fat diet
(HFD) for 24 weeks. Female mice gained more adipose mass and lost more lean mass
than males but reached similar visceral adipose mass and body weight, as males, at the
end of the diet. 24 weeks of HFD matched male and female mice for visceral adiposity,
glycaemia, plasma insulin, lipids, and inflammatory cytokines levels, demonstrating the
suitability of the model to study human pathology. HFD did not elevate BP, but similarly
increased heart rate (HR) in males (CD: 571 ± 9 vs. HFD: 631 ± 14 bpm, P < 0.05)
and females (CD: 589 ± 19 vs. HFD: 642 ± 6 bpm, P < 0.05). Indices of autonomic
control of BP and HR were obtained by measuring BP and HR response to ganglionic
blockade, β-adrenergic, and muscarinic receptors antagonists. HFD increased vascular
but reduced cardiac sympathetic drive in males (CD: –43 ± 4 and HFD: –60 ± 7%
drop in BP, P < 0.05). HFD did not alter females’ vascular or cardiac sympathetic
drive. HFD specifically reduced aortic α-adrenergic constriction in males and lowered
HR response to muscarinic receptor antagonism in females. These data suggest that
obesity-associated increases in HR could be caused by a reduced cardiac vagal tone
in females, while HR increases in males may compensate for the reduced vascular
adrenergic contractility to preserve baseline BP. These data suggest that obesity impairs
autonomic control of cardiovascular function in males and females, via sex-specific
mechanisms and independent of fat distribution, metabolic disorder or inflammation.
Keywords: high fat diet, blood pressure, heart rate, vagal tone, vascular adrenergic reactivity, obesity,
inflammation, visceral adipose tissue
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INTRODUCTION
The worldwide epidemic of obesity is a leading risk factor
for cardiovascular disease (CVD) and a major health burden,
in men and women. Due to the protective effects of female
sex hormones on the cardiovascular system (Barrett-Connor
and Bush, 1991; Mosca et al., 2011), young adult women have
been for a long time ignored in clinical cardiovascular study
from cohorts and experiments on mechanisms of CVD in basic
research (Wizemann and Pardue, 2001; Beery and Zucker, 2011).
However, young adult women are severely affected by the current
epidemic of obesity (Ogden et al., 2014). They are indeed more
prone to obesity than men of the same age and develop more
severe forms of obesity (Shields et al., 2011). Notably, the
percentage of women suffering from obesity class II and class
III is the double of the percentage of men, in the United States
and Canada (Flegal et al., 2010; Shields et al., 2011; Ogden
et al., 2013, 2014). This rising prevalence of obesity has been
associated with a three-fold increase in the incidence of stroke
and hypertension and with a stagnation in the number of death
from acute myocardial infarction, in women of reproductive age,
whereas a decrease is observed in men of the same age (Towfighi
et al., 2010, 2011; Wilmot et al., 2015). Despite these alarming
data the mechanisms whereby increases in body weight promote
CVD in young women remains incompletely understood, and
poorly studied.
A shift of the autonomic balance toward an increased
sympathetic activity is a common feature of obesity, and
a major contributing factor to obesity-related CVD, notably
hypertension, in men and male animal models. While it is clearly
established that premenopausal women have a lower sympathetic
activity than men of the same age (Jones et al., 1996; Matsukawa
et al., 1998; Bell et al., 2001; Christou et al., 2005; Messina et al.,
2013), it is however unclear whether body weight gain elevates
sympathetic activity in females, as it does in males of the same
age. Indeed, while a first study reported that muscle sympathetic
nerve activity (MSNA) correlates with the percentage of body fat
in both young male and female adults (Jones et al., 1996), others
did not find correlations between body mass index and MSNA
in women (Lambert et al., 2007; Tank et al., 2008). In addition,
decreases in body weight have been reported to reduce MSNA in
men only (Lambert et al., 2007). Thus, obesity appears to increase
MSNA in men, but not or less so in women. The present study
aimed to further analyze whether obesity impairs autonomic
balance in females, as it does in males and to investigate the
mechanism underlying a potential sex difference.
A major complication to the study of the autonomic and
cardiovascular responses to diet-induced obesity is the sexual
dimorphism in body weight gain, body composition, metabolic
alterations, and inflammation. Evidence from the literature
indicates that female sex appears to reduce the magnitude of
the metabolic and inflammatory disorders induced by chronic
HFD treatment (Gupte et al., 2012; Pettersson et al., 2012;
Ganz et al., 2014; Singer et al., 2015). This sexual dimorphism
in the metabolic and inflammatory responses to short term
HFD treatments response may likely contribute to the mild
cardiovascular alterations reported in obese female rodents.
In opposition to female rodents, young adult women are not
protected from obesity-associated metabolic and inflammatory
disorders, and appear more prone to obesity-related CVD than
men (Thorand et al., 2007; Alemzadeh and Kichler, 2014;
Pradhan, 2014; Garcia et al., 2016), which suggests that current
murine models of diet-induced obesity are inappropriate and
create the need for new animal models better mimicking the
human pathology. Therefore, the present study also aimed
at developing a mouse model closely mimicking the human
scenario, which would allow testing the hypothesis that sex
differences in cardiovascular responses to body weight gain
disappear in mice matched for changes in body weight, and in
metabolic and inflammatory indices. Because obesity in humans
is generally a long-term event, this study also aimed to determine
if metabolic and inflammatory differences are muted with a
prolonged HFD treatment.
MATERIAL AND METHODS
Animals
All surgical procedures and experimental protocols were
approved by the Institutional Animal Care and Use Committee
of Augusta University, in accordance with the guide for the care
and use of laboratory animals published by National Institute
of Health (National Research Council (US) Committee for the
Update of the Guide for the Care and Use of Laboratory Animals,
2011). Male and female C57Bl/6 mice (6 weeks of age, Jackson
Laboratory, Bar Harbor, ME) were divided in 4 groups and fed
either a control diet (CD; BioServ, F6256, Carbohydrate 62%, Fat
17%, Protein 21% kcal, Sodium 0.4%) or a high-fat diet (HFD;
BioServ, F2685, 60% of fat calories from lard: Carbohydrate
26%, Fat 59%, Protein 15% kcal, Sodium 0.4%, Diet F3282) ad
libitum. Tap water was provided ad libitum. Based on a pilot study
(unpublished data), it was determined that 21 weeks of HFD are
required for male and female mice to develop a similar level of
obesity. Mice were monitored for 24 weeks. Body weight was
measured twice weekly. Food intake was determined in a sub-
group of animals placed in metabolic cages for 3 days, 21 weeks
after the initiation of the HFD treatment. Mice were housed in
an American Association of Laboratory Animal Care–approved
animal care facility at Augusta University.
Body Composition
After 21 weeks of control or HFD, body composition was
analyzed by nuclear magnetic resonance spectroscopy [EchoMRI
(magnetic resonance imaging)](Bruder-Nascimento et al., 2015)
and confirmed by direct measurement of fat pad weights
(Perigonadal fat pads) at the time of euthanasia (24 weeks).
In vivo Blood Pressure Measurement
After 21 weeks of control or HFD mice were instrumented
with telemetry transmitters to record arterial pressure and heart
rate (PA-C10, Data Sciences, St Paul, MN). Transmitters were
implanted as described previously (Belin de Chantemèle et al.,
2009; Huby et al., 2016). After 7 to 14 days of recovery from
surgery, necessary for the mice to gain their initial body weight,
data were recorded for 7 days. Blood pressure and heart rate
values were obtained at 10-min intervals for the duration of the
study. Mean values were collected from 24-h averages.
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Indices of Autonomic Function
Indices of the autonomic function were obtained on the last
day of the recording period using a standard pharmacological
method involving a single intraperitoneal injection of the
ganglionic blocker mecamylamine (5 mg/kg), of the β-adrenergic
receptor blocker propranolol (6 mg/kg) and of the muscarinic
receptor blocker atropine (1 mg/kg) in conscious mice (Belin
de Chantemèle et al., 2009; Huby et al., 2016). Injections were
conducted more than 2 h apart in a random order. Maximal
blood pressure or heart rate response to blockers within 10 min
post-injection was reported. Changes in mean arterial pressure
(MAP) or heart rate were expressed as percent of the baseline
MAP or heart rate.
Metabolic Profile
Once the blood pressure experiments terminated, fasted
mice were anesthetized (isoflurane 5%) and euthanized via
decapitation, in accordance with our approved animal protocol.
Trunk blood and organs were respectively collected for
plasma isolation and weight measurement. Fasting blood
glucose and HbA1c levels were measured using a glucometer
(AlphaTRAK, Abbott, USA) and A1CNow (Metrika, Terrytown,
NY) respectively. Plasma total cholesterol and triglycerides were
measured with enzymatic colorimetric assays (Wako, Richmond,
VA, USA). Plasma insulin and leptin levels were determined
using ELISA kits from ALPCO Diagnostics (Salem, NH, USA)
(Belin de Chantemèle et al., 2012).
Inflammatory Profile
Plasma IL-6 and TNF-α levels were measured with EZMIL6 and
EZMTNFA ELISA assay kits (Millipore, USA), respectively.
Vascular Reactivity
Thoracic aortas were dissected surgically, cleaned of fat, cut in
2 mm-long rings and mounted on a wire myograph (DMT,
Aarhus, Denmark) with 1 g of basal tension (Belin de Chantemèle
et al., 2009, 2011). Briefly, 2 tungsten wires were inserted into
the lumen of the arteries and fixed to a force transducer and a
micrometer. Arteries were bathed in a physiological salt solution
and arterial viability was determined with a potassium-rich
solution (KCl, 40 mmol/L). Cumulative concentration-response
curves to phenylephrine (Phe); (0.1ηmol/L to 100 µmol/L),
serotonin (5-HT); (0.1 ηmol/L to 100 µmol/L), acetylcholine
(ACh); (0.1 ηmol/L to 100 µmol/L) and sodium nitroprusside
(SNP); (0.1 ηmol/L to 10 µmol/L) were conducted. The
relaxation in response to ACh and SNP is expressed as percentage
of the preconstriction with serotonin (5-HT, 0.1 µM). The
response to phenylephrine is expressed as a percentage of KCl-
mediated constriction (Belin de Chantemèle et al., 2009, 2011).
Statistical Analysis
All data are expressed as means ± SEM. Data were analyzed
using a two-way analysis of variance (ANOVA) followed by
a Bonferroni post-hoc test comparing sex, diet, and their
interaction (GraphPad Prism 7; GraphPad Software Inc., La Jolla,
CA). For all comparisons, P < 0.05 was considered statistically
significant.
RESULTS
Metabolic Profile
At 6 weeks of age male and female mice had comparable
body weight (Table 1). In response to CD males presented a
larger increase in body weight as compared to females. In
response to HFD males exhibited a faster increase in body
weight as compared to females, but both male and female mice
reached a similar body weight after 21 weeks of HFD treatment
(Figure 1A). Body composition analysis via NMR spectroscopy
revealed that females had a larger increase in body fat (Figure 1B)
and a more pronounced reduction in lean mass (Figure 1C)
in response to HFD, as compared to males, despite a similar
increase in caloric intake (Figure 1D). Male and females mice
exhibited a similar increase in kidney weight withHFD.However,
males have a larger increase in heart weight compared to females
(Table 1).
Circulating levels of the adipocyte-derived hormone leptin
were similarly increased in male and female mice on the HFD
(Table 2). Glycemia, HbA1C, insulin, and cholesterol levels were
also similarly increased with HFD in male and female mice
(Table 2).
Inflammatory Profile
As inflammation is a common feature of obesity we measured
plasma levels of two cytokines associated with the progression
of CVD, IL-6, and TNF-α (Ridker et al., 2000; Gao et al.,
2007; Empana et al., 2010; Ammirati et al., 2012), in our 4
groups of mice. These experiments revealed that HFD induced a
comparable increase in pro-inflammatory cytokines in male and
females mice (Table 2).
Blood Pressure and Heart Rate
To determine whether HFD-induced obesity affects blood
pressure, mice were instrumented with radiotelemeter. As
reported in Figure 2, no difference in blood pressure was
observed between male and female mice on CD. Similarly,
HFD did not elevate mean (Figure 2A), systolic (Figure 2B)
or diastolic (Figure 2C) blood pressure in either male or
female mice. HFD did however significantly raised heart rate
TABLE 1 | Body and organs weight.
Male Female
CD HFD CD HFD
Initial body weight (g) 11.3 ± 1.2 10.0 ± 1.6 9.9 ± 1.3 10.5 ± 1.5
Final body weight (g) 36.3 ± 4.8 50.8 ± 8.1* 24.5 ± 2.9† 47.9 ± 7.9*
Perigonadal fat/tibia
(mg/mm)
73.7 ± 14.3 140.0 ± 17.6* 70.5 ± 7.1 150.7 ± 17.1*
Heart/tibia (mg/mm) 7.6 ± 0.3 9.2 ± 0.3* 7.1 ± 0.5 8.3 ± 0.3*
Adrenal/tibia
(mg/mm)
0.18 ± 0.02 0.27 ± 0.02* 0.22 ± 0.1 0.37 ± 0.1*
Kidney/tibia
(mg/mm)
18.6 ± 1.2 22.3 ± 0.7* 17.7 ± 3.1 21.3 ± 0.9*
Data are expressed as means ± SEM. *P < 0.05 vs. respective lean mice;
†
P < 0.05 vs.
lean male mice. (n per group: CD male: 7; CD female: 5; HFD male: 5; HFD female: 6).
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FIGURE 1 | Effects of 24 weeks of high-fat diet on body weight and body composition in male and female mice. (A) Body weight of control (CD) and high
fat (HFD)-fed mice (g), (B) Percentage of body fat and (C) lean mass measured by nuclear magnetic resonance spectroscopy (EchoMRI). (D) Caloric intake (Kcal x g)
in control and high fat-fed male and female mice. Data are presented as mean ± SEM. *P < 0.05 vs. control diet within sex group; †P < 0.05 vs. high-fat diet within
sex group; ‡P < 0.05 vs. control male mice. (n per group: CD male: 10; CD female: 9; HFD male: 10; HFD female: 10).
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to a similar extent in male and female mice (Figure 2D),
suggesting a potential impairment in the autonomic control of
the cardiovascular function. Autonomic function was assessed
acutely, in conscious mice, with randomized injections of
TABLE 2 | Basic physiological and metabolic parameters of control and
high-fat diet mice.
Male Female
CD HFD CD HFD
Leptin (ng/mL) 4.1 ± 0.9 10.2 ± 0.9* 4.7 ± 1.1 11.9 ± 1.4*
Insulin (ng/mL) 66.3 ± 17.1 512.6 ± 43.7* 59.4 ± 6.9 496.7 ± 54.5*
Cholesterol (mmol/L) 0.29 ± 0.04 0.37 ± 0.03* 0.27 ± 0.06 0.38 ± 0.04*
Triglycerides 0.89 ± 0.20 0.91 ± 0.19 0.86 ± 0.38 0.87 ± 0.24
(mmol/L)
Glycemia (mg/dL) 137.0 ± 18.0 196.9 ± 13.0* 115.3 ± 21.5 179.10 ± 18.2*
Hb1AC 4.7 ± 0.1 5.6 ± 0.3* 4.5 ± 0.2 5.8 ± 0.3*
IL-6 (pg/mL) 14.2 ± 1.8 40.9 ± 10.0* 9.2 ± 3.8 48.2 ± 17.9*
TNF-α (pg/mL) 15.1 ± 1.8 47.7 ± 8.4* 18.3 ± 1.6 53.2 ± 4.9*
Data are expressed as means ± SEM. *P < 0.05 vs. respective lean mice. (n per group:
CD male: 7; CD female: 5; HFD male: 5; HFD female: 6).
sympatholytic drugs and vagal blockers. Blood pressure response
to ganglionic blockade revealed a significant increase in vascular
sympathetic drive in males submitted to HFD, while obesity was
without effect on BP response to ganglionic blockade in females
(Figure 3). Ganglionic blockade tended to reduce (Figure 4A),
while β-adrenergic receptor antagonism significantly lowered
heart rate in male HFDmice (Figure 4B), supporting a reduction
in cardiac sympathetic tone with obesity in males. HFD did not
alter female’s heart rate response to either ganglionic blockade
(Figure 4A) or propranolol injection (Figure 4B), suggesting no
effects of obesity on cardiac sympathetic tone in female mice.
Heart rate response to muscarinic receptor antagonism was used
as an index of vagal tone. As reported in Figure 4C, leanmale and
female mice exhibit similar level of vagal tone. Obesity markedly
reduced vagal tone in female mice only (Figure 4C).
Vascular Function
Several studies from our group demonstrate an interaction
between sympathetic activity and vascular adrenergic tone,
notably report that increased vascular sympathetic tone leads
to a reduction in vascular adrenergic contractility (Belin de
Chantemèle et al., 2009, 2011; Bruder-Nascimento et al., 2015).
Vascular reactivity experiments revealed no difference in vascular
FIGURE 2 | Twenty-four weeks of high-fat diet preserved blood pressure but increased hear rate in male and female mice. (A) Mean, (B) systolic and (C)
diastolic blood pressure and, (D) heart rate of control (CD) and high-fat diet (HFD) male and female mice, measured by radio-telemetry. Data are presented as mean ±
SEM. *P < 0.05 vs. control diet within sex group. (n per group: CD male: 6; CD female: 5; HFD male: 6; HFD female: 5)
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adrenergic reactivity between lean male and female mice but
reported that HFD markedly reduced aortic constriction to
phenylephrine in male mice only (Figures 5A,B). Vascular
constriction to serotonin (5-HT) and depolarization (KCl) were
neither affected by sex nor the diet (Figures 5C–E). Analysis of
the endothelial function via concentration-response curves to
acetylcholine (ACh) revealed no difference between males and
females and no effects of the diet (Figures 6A,B). Similarly, sex
and diet had no effect on endothelium-independent relaxation
(SNP, Figures 6C,D).
DISCUSSION
The present study aimed to characterize the sex-specificity of
the response of the autonomic nervous system to obesity and
FIGURE 3 | Twenty-four weeks of high-fat diet increased vascular
sympathetic tone in male mice. Changes in mean arterial pressure in
response to mecamylamine [ganglionic blocker (5 mg/Kg i.p)] in control- (CD)
and high fat-fed (HFD) male and female mice, measured by radio-telemetry in
conscious animals. Data are expressed as percentage of basal condition. Data
are presented as mean ± SEM. *P < 0.05 vs. control diet within sex group;
†P < 0.05 vs. male/ female within diet group. (n per group: CD male: 5; CD
female: 5; HFD male: 6; HFD female: 5)
to identify the origin of potential sex differences. We investigate
the potential contribution of body weight, metabolic disorders,
and inflammation to the autonomic imbalance associated with
obesity and tested the hypothesis that the sexual dimorphism in
the autonomic response to obesity disappears in mice matched
for changes in body weight, metabolic and inflammatory
disorders. The main findings of this study are that prolonged
HFD treatment: (1) similarly increased body weight in male and
female mice and abolished the sexual dimorphism in metabolic
and inflammatory responses to obesity observed with short-
term HFD treatments, (2) did not elevate blood pressure but
increased heart rate to a similar extent in male and female
mice, and (3) revealed a sex-specific response of the autonomic
nervous system to obesity reflected by an enhanced vascular
neurogenic support of blood pressure in males, a lower cardiac
sympathetic tone in males and a reduced cardiac vagal tone in
female mice. Relevant to these observations is the mouse model
of obesity, the dimorphic response of the autonomic nervous
system to obesity and the demonstration that, in agreement
with our initial hypothesis, similar levels of adiposity, metabolic
and inflammatory disorders impair autonomic control of the
cardiovascular system in male and female mice.
Compelling evidence from the literature indicates that
induction of obesity with a relative short HFD treatment in
rodents induces a sexual dimorphism in body weight, fat
distribution, metabolic alterations, and degree of inflammation.
Indeed, after 8–16 weeks of HFD, femalemice are generally leaner
and do habitually exhibit reduced increases in body weight,
preserved metabolic function and lower degree of inflammation
as compared to their male counterparts (Gupte et al., 2012;
Pettersson et al., 2012; Ganz et al., 2014; Singer et al., 2015;
Jeffery et al., 2016). Amount and distribution of body fat
appear as two major factors contributing to the degree of
metabolic, inflammatory and cardiovascular disorders associated
with obesity (Alvarez et al., 2002; Després, 2012). Therefore, the
limited increase in fat mass, mostly restricted to the subcutaneous
area (Jeffery et al., 2016), likely explains the absence or the mild
cardiovascular disorders developed by female mice submitted to
short-term HFD treatments. In opposition to obese female mice,
obese women exhibit increased visceral adipose tissue and severe
FIGURE 4 | Twenty-four weeks of high-fat diet decreased cardiac sympathetic tone in male and reduced cardiac vagal tone in female mice. Changes in
heart rate in response to (A) mecamylamine [ganglionic blocker (5 mg/Kg i.p)], (B) propranolol [β-adrenergic receptor blocker (6 mg/kg)], and (C) atropine [muscarinic
antagonist (5 mg/Kg i.p)] in control- (CD) and high fat-fed (HFD) male and female mice, measured by radio-telemetry in conscious animals. Data are expressed as
percentage of basal condition. Data are presented as mean ± SEM. *P < 0.05 vs. control diet within sex group; †P < 0.05 vs. male/ female within diet group. (n per
group: CD male: 5; CD female: 5; HFD male: 6; HFD female: 5)
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FIGURE 5 | Twenty-four weeks of high-fat diet reduced vascular adrenergic tone in male mice only. Cumulative concentration-response curves to
phenylephrine and serotonin (5-HT) performed in aortic rings taken from control- (CD) and high fat fed (HFD) male (A,C) and female (B,D) mice and (E) KCl-induced
vascular contractility measured in aortic rings taken from control- (CD) and high fat-fed (HFD) male and female mice. Data are expressed as percentage of
KCl-induced contractility. Data are presented as mean ± SEM. *P < 0.05 vs. control diet within sex group; †P < 0.05 vs. high-fat diet within sex group. (n per group:
CD male: 5; CD female: 5; HFD male: 5; HFD female: 6).
metabolic and inflammatory alterations (Go et al., 2013; Ogden
et al., 2013). Thus, the discrepancy between the murine and the
human phenotype raises the question of the appropriateness of
the murine models currently used. Here we showed for the first
time that a long-term HFD treatment abolishes the dimorphic
response to HFD revealed with short HFD treatments and
provides an appropriate model to study the human scenario.
Indeed, female mice initially leaner than males exhibited, with
24 weeks of HFD, larger increases in adipose mass to reached
similar levels of visceral fat mass and similar degrees of metabolic
dysfunction and inflammation as males, as observed in obese
humans. These data indicate that we have generated an adequate
murine model and a powerful tool to study the human pathology
and investigate whether obesity induces CVD and autonomic
imbalance via sex-specific mechanisms.
With this mouse model, no increase in blood pressure with
obesity was reported in any of the sexes, despite the long
duration of the HFD treatment and the large increases in body
weight. Although these data could appear controversial, they are
in accordance with previous results by our group and others
reporting no elevation in blood pressure in male and female mice
submitted to long-term HFD treatments (Belin de Chantemèle
et al., 2011; Pettersson et al., 2012; Böhm et al., 2013; Calligaris
et al., 2013; Jia et al., 2015; Xu et al., 2015). Despite the lack of
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FIGURE 6 | Twenty-four weeks of high-fat diet preserved vascular relaxation in male and female mice. Cumulative concentration-response curves to
acetylcholine (ACh) and Sodium Nitroprusside (SNP) performed in aortic rings taken from control- (CD) and high fat-fed (HFD) male (A,C) and female (B,D) mice. Data
are presented as mean ± SEM. (n per group: CD male: 5; CD female: 5; HFD male: 5; HFD female: 6)
increase in blood pressure, we identified sex-specific alterations
of the autonomic control of cardiovascular function. We showed
that obesity increased vascular but reduced cardiac sympathetic
tone in male animals. Obesity was without effects on vascular
and cardiac sympathetic tone in female mice but triggered
a cardiac parasympathetic withdrawal. Interestingly these sex-
specific shifts of the autonomic balance are associated a similar
alteration of the cardiac function. Indeed, HFD induced a similar
elevation in heart rate in male and female mice. These data
are consistent with the human literature reporting increased
heart rate in obese patients (Narkiewicz et al., 1999; Nault
et al., 2007) and indicating that body weight gain leads to a
cardiac parasympathetic withdrawal in a population consisted of
a majority of premenopausal women (7 men, 16 women) (Rossi
et al., 1989) when weight lost induces a significant increase in
cardiac vagal tone, independent of changes in blood pressure, in
obese women (Rissanen et al., 2001; Poirier et al., 2003). Thus,
reduced cardiac vagal tone appears as a likely explanation for the
increased heart rate reported in obese female mice.
HFD did not affect vagal tone in males but, in agreement
with the human (Vaz et al., 1997) and rodent literature (Thaung
et al., 2015), induced a reduction in cardiac β-adrenergic tone,
which has been postulated to be the response to the circulatory
overloading (Messerli et al., 1983) brought on by high renal
sympathetic nervous activity and sodium retention (Esler et al.,
2006; Hall et al., 2015). Therefore, the increased heart rate
reported in obese male animals may be the reflection of an
increased intrinsic cardiac electrical activity.
In opposition to obese female mice, obese male mice present
increased peripheral neurogenic control of blood pressure as
shown by a larger decrease in blood pressure in response to
acute ganglionic blockade. Consistent with our previous studies
(Belin de Chantemèle et al., 2009, 2011; Bruder-Nascimento et al.,
2015) we reported that this increase in vascular sympathetic
tone is associated with a reduced aortic adrenergic contractility.
Although the aorta is a conduit vessel playing minor roles in
blood pressure control, it develops, as the resistance arteries,
a reduced adrenergic contractility in response to increased
sympathetic tone (Belin de Chantemèle et al., 2009, 2011). As
suggested previously (Belin de Chantemèle et al., 2011), these
data, although indirect, may support a decreased total peripheral
resistances in obese male mice. The lack of increase in blood
pressure, despite the significant and important elevation in heart
rate, represent further arguments to support a decrease in total
peripheral resistance in males animals. Indeed, improved renal
function and decreased cardiac output appear unlikely in amouse
model that exhibit cardiac and renal hypertrophy, metabolic
disorders as well as inflammation. This may indicate that the
increase in heart rate reported in obese male animals is likely
the combination of compensatory mechanisms developed to
preserve physiological blood pressure levels in the presence of
reduced total peripheral resistance.
Previous work from our group demonstrated that the
reduction in vascular adrenergic reactivity is the direct
consequence of an increased sympathetic tone (Belin de
Chantemèle et al., 2009, 2011; Bruder-Nascimento et al., 2015).
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This close interaction between sympathetic tone and vascular
adrenergic reactivity explains why obese femalemice, that did not
exhibit increased vascular sympathetic tone, present a preserved
aortic adrenergic contractility. Despite metabolic alterations and
inflammation, no endothelial dysfunction was reported in aortic
rings from obese male and female mice. A preserved aortic
endothelial function in rodents exposed to HFD was reported
by our group on diverse occasions (Belin de Chantemèle et al.,
2011; Stepp et al., 2013; Huby et al., 2016). It has been postulated
that the increased cardiac output associated with obesity (Belin
de Chantemèle et al., 2011) and its consequent increase in
aortic blood flow and shear stress could contribute to the
preserved aortic endothelial function despite the presence of
metabolic dysfunctions and increased sympathetic activity (Belin
de Chantemèle et al., 2011; Huby et al., 2016).
A major goal of the present study was the address the question
of the potential mechanisms leading to the sex-specific response
of the cardiovascular system to obesity. We investigated whether
adiposity, fat distribution, metabolic disorder, and inflammation
could potentially contribute to the development of obesity-
related autonomic impairments. We reported that matching
male and female mice for body weight, visceral adiposity,
glycaemia, plasma lipid profile, and degree of inflammation
impaired autonomic control of cardiovascular function in both
sexes. However, the nature of the autonomic dysfunction appears
sex-specific. Indeed, while males exhibit an increased vascular
sympathetic tone, females developed a cardiac parasympathetic
withdrawal. The sex-specificity of the autonomic impairment
cannot be explained by different metabolic or inflammatory
responses to obesity, which suggest the contribution of sex
hormones. Estrogen is known to exert sympatho-inhibitory
actions (Dart et al., 2002; Hay, 2016) and increase vagal
tone (Saleh and Connell, 2000). In addition, long-term HFD
treatment has been shown to reduced estrogen levels (Bryzgalova
et al., 2008). Therefore, we can speculate that obesity-associated
reduction in estrogen levels contributes to the decrease in
parasympathetic activity observed in obese female mice. The
hypothesis of the estrogen contribution to the sex-specific
response of the autonomic nervous system to obesity, would
also indicate that, despite reduced, estrogens levels are still high
enough to prevent the increase in sympathetic activity associated
with increases in visceral adipose tissue (Alvarez et al., 2002).
Metabolic hormones such as insulin, the levels of which are
significantly increased with obesity, may also contribute to the
sex specific response of the autonomic nervous system to obesity,
notably play a role in the decreased vagal tone. Indeed, a study
conducted in small population of a majority of women (5 men,
11 women) indicated that hypersinsulinemia reduced vagal tone
(VanDe Borne et al., 1999). Nevertheless, further experiments are
required to investigate the respective contribution of sex steroids
and metabolic hormones to the autonomic imbalance induced by
obesity.
In summary, our data emphasize for the first time the
importance of comparing male and female animals of
similar weight, fat distribution, and degree of metabolic
and inflammatory disorders, in obesity studies, and demonstrate
that at least 21 weeks of HFD treatment are required to generate a
mouse model that mimics the human pathology. With these very
specific conditions, we identified a sex-specific response of the
autonomic nervous system to obesity that is neither influence by
fat distribution nor by the degree of metabolic and inflammatory
disorders but likely requires the intervention of sex steroids. The
mouse model generated provides an excellent tool to further
study the contribution of sex-steroids to the autonomic response
to obesity.
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